The outbreak stems from contaminated drugs from the New England Compounding Center in Framingham, Mass., which have been linked to 32 deaths and more than 438 illnesses.
Food and Drug Administration Commissioner Margaret Hamburg, MD, proposed a framework that would increase the FDA’s oversight of compounding pharmacies, saying “gaps and ambiguities in the law” have hindered the FDA’s ability to inspect pharmacies, according to the report.
NECC’s president and co-owner, Barry Cadden, exercised his Fifth Amendment right and did not testify.
The Senate Health, Education, Labor and Pensions Committee will hold a separate hearing on the outbreak Thursday.
More Articles on the Meningitis Outbreak:
Two More NECC Products Positive for Bacterial Contamination
6 Scariest Issues in Healthcare Right Now
FDA: Avoid Meningitis Contamination, Discontinue Use of New England Compounding Center Products
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.